drugset / Trial / NCT07119242

Evaluate the Diagnostic Efficacy, Pharmacokinetics and Safety of 68Ga-DOTATATE Injection PET/CT in NETs

NCT07119242 ↗

Phase 3 Active not recruiting 95 enrolled HTA Co., Ltd.
NaSingle-groupOpen-labelDiagnostic

Summary

Evaluate the diagnostic efficacy, pharmacokinetics and safety of 68Ga-DOTATATE injection PET/CT in NETs

Timeline

Start
2024-01-08
Primary completion
2024-11-11
Completion
2025-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject 68Ga-DOTATATE Injection Diagnostic / imaging agent — Intravenous